English
简体中文
Total: £ 56.28
Published Date: 2025-04-24 | Pages: 105 | Tables: 106 | Medical Care
The global Viral Vectors and Plasmid DNA Manufacturing market size was US$ 844 million in 2024 and is forecast to a readjusted size of US$ 2649 million by 2031 with a CAGR of 18.0% during the forecast period 2025-2031.
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Global Viral Vectors and Plasmid DNA Manufacturing key players include BioReliance, Oxford BioMedica, UniQure, Cobra Biologics, etc. Global top four manufacturers hold a share over 45%.
North America is the largest market, with a share about 50%, followed by Asia-Pacific, and Europe, both have a share over 40 percent.
In terms of product, Viral Vectors is the largest segment, with a share about 80%. And in terms of application, the largest application is Cancers, followed by Inherited Disorders, Viral Infections , etc.
The global Viral Vectors and Plasmid DNA Manufacturing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Thermo Fisher Scientific (Brammer Bio)
VGXI
PlasmidFactory
By Type: (Dominant Segment vs High-Margin Innovation)
Plasmid DNA
Viral Vectors
By Application: (Core Demand Driver vs Emerging Opportunity)
Cancers
Inherited Disorders
Viral Infections
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., BioReliance in Europe)
- Emerging Product Trends: Plasmid DNA adoption vs. Viral Vectors premiumization
- Demand-Side Dynamics: Cancers growth in China vs. Inherited Disorders potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Viral Vectors and Plasmid DNA Manufacturing market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Viral Vectors in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Inherited Disorders in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Viral Vectors and Plasmid DNA Manufacturing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Plasmid DNA
1.2.3 Viral Vectors
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region (2020-2025)
2.4 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospective (2020-2031)
2.5.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospective (2020-2031)
2.5.3 China Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospective (2020-2031)
2.5.4 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Type (2020-2025)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2026-2031)
3.3 Different Types Viral Vectors and Plasmid DNA Manufacturing Representative Players
4 Breakdown Data by Application
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Historic Market Size by Application (2020-2025)
4.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Viral Vectors and Plasmid DNA Manufacturing Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Revenue (2020-2025)
5.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Viral Vectors and Plasmid DNA Manufacturing Revenue
5.4 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Analysis
5.4.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2024
5.5 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing Head office and Area Served
5.6 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Product and Application
5.7 Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025)
6.1.2.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025)
6.1.3.2 North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025)
6.2.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025)
6.2.3.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025)
6.3.2.2 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025)
6.3.3.2 China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025)
6.4.2.2 Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025)
6.4.3.2 Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 BioReliance
7.1.1 BioReliance Company Details
7.1.2 BioReliance Business Overview
7.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Introduction
7.1.4 BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.1.5 BioReliance Recent Development
7.2 Cobra Biologics
7.2.1 Cobra Biologics Company Details
7.2.2 Cobra Biologics Business Overview
7.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Introduction
7.2.4 Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.2.5 Cobra Biologics Recent Development
7.3 Oxford BioMedica
7.3.1 Oxford BioMedica Company Details
7.3.2 Oxford BioMedica Business Overview
7.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Introduction
7.3.4 Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.3.5 Oxford BioMedica Recent Development
7.4 UniQure
7.4.1 UniQure Company Details
7.4.2 UniQure Business Overview
7.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Introduction
7.4.4 UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.4.5 UniQure Recent Development
7.5 FinVector
7.5.1 FinVector Company Details
7.5.2 FinVector Business Overview
7.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Introduction
7.5.4 FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.5.5 FinVector Recent Development
7.6 MolMed
7.6.1 MolMed Company Details
7.6.2 MolMed Business Overview
7.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Introduction
7.6.4 MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.6.5 MolMed Recent Development
7.7 MassBiologics
7.7.1 MassBiologics Company Details
7.7.2 MassBiologics Business Overview
7.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Introduction
7.7.4 MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.7.5 MassBiologics Recent Development
7.8 Richter-Helm
7.8.1 Richter-Helm Company Details
7.8.2 Richter-Helm Business Overview
7.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Introduction
7.8.4 Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.8.5 Richter-Helm Recent Development
7.9 FUJIFILM Diosynth Biotechnologies
7.9.1 FUJIFILM Diosynth Biotechnologies Company Details
7.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Introduction
7.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
7.10 Lonza
7.10.1 Lonza Company Details
7.10.2 Lonza Business Overview
7.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Introduction
7.10.4 Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.10.5 Lonza Recent Development
7.11 Aldevron
7.11.1 Aldevron Company Details
7.11.2 Aldevron Business Overview
7.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Introduction
7.11.4 Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.11.5 Aldevron Recent Development
7.12 Eurogentec
7.12.1 Eurogentec Company Details
7.12.2 Eurogentec Business Overview
7.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Introduction
7.12.4 Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.12.5 Eurogentec Recent Development
7.13 Cell and Gene Therapy Catapult
7.13.1 Cell and Gene Therapy Catapult Company Details
7.13.2 Cell and Gene Therapy Catapult Business Overview
7.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Introduction
7.13.4 Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.13.5 Cell and Gene Therapy Catapult Recent Development
7.14 Biovian
7.14.1 Biovian Company Details
7.14.2 Biovian Business Overview
7.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Introduction
7.14.4 Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.14.5 Biovian Recent Development
7.15 Thermo Fisher Scientific (Brammer Bio)
7.15.1 Thermo Fisher Scientific (Brammer Bio) Company Details
7.15.2 Thermo Fisher Scientific (Brammer Bio) Business Overview
7.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Introduction
7.15.4 Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Development
7.16 VGXI
7.16.1 VGXI Company Details
7.16.2 VGXI Business Overview
7.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Introduction
7.16.4 VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.16.5 VGXI Recent Development
7.17 PlasmidFactory
7.17.1 PlasmidFactory Company Details
7.17.2 PlasmidFactory Business Overview
7.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Introduction
7.17.4 PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
7.17.5 PlasmidFactory Recent Development
8 Viral Vectors and Plasmid DNA Manufacturing Market Dynamics
8.1 Viral Vectors and Plasmid DNA Manufacturing Industry Trends
8.2 Viral Vectors and Plasmid DNA Manufacturing Market Drivers
8.3 Viral Vectors and Plasmid DNA Manufacturing Market Challenges
8.4 Viral Vectors and Plasmid DNA Manufacturing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share by Region (2020-2025)
Table 6. Global Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Share Forecast by Region (2026-2031)
Table 8. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2020-2025)
Table 10. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2020-2025)
Table 15. Global Viral Vectors and Plasmid DNA Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Viral Vectors and Plasmid DNA Manufacturing Application
Table 18. Global Viral Vectors and Plasmid DNA Manufacturing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players (2020-2025)
Table 20. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2024)
Table 21. Ranking of Global Top Viral Vectors and Plasmid DNA Manufacturing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Headquarters and Area Served
Table 24. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Product and Application
Table 25. Global Key Players of Viral Vectors and Plasmid DNA Manufacturing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2020-2025)
Table 29. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2020-2025)
Table 33. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2020-2025)
Table 37. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Company (2020-2025)
Table 41. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Viral Vectors and Plasmid DNA Manufacturing Market Size by Application (2020-2025) & (US$ Million)
Table 43. BioReliance Company Details
Table 44. BioReliance Business Overview
Table 45. BioReliance Viral Vectors and Plasmid DNA Manufacturing Product
Table 46. BioReliance Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 47. BioReliance Recent Development
Table 48. Cobra Biologics Company Details
Table 49. Cobra Biologics Business Overview
Table 50. Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 51. Cobra Biologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 52. Cobra Biologics Recent Development
Table 53. Oxford BioMedica Company Details
Table 54. Oxford BioMedica Business Overview
Table 55. Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product
Table 56. Oxford BioMedica Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 57. Oxford BioMedica Recent Development
Table 58. UniQure Company Details
Table 59. UniQure Business Overview
Table 60. UniQure Viral Vectors and Plasmid DNA Manufacturing Product
Table 61. UniQure Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 62. UniQure Recent Development
Table 63. FinVector Company Details
Table 64. FinVector Business Overview
Table 65. FinVector Viral Vectors and Plasmid DNA Manufacturing Product
Table 66. FinVector Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 67. FinVector Recent Development
Table 68. MolMed Company Details
Table 69. MolMed Business Overview
Table 70. MolMed Viral Vectors and Plasmid DNA Manufacturing Product
Table 71. MolMed Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 72. MolMed Recent Development
Table 73. MassBiologics Company Details
Table 74. MassBiologics Business Overview
Table 75. MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product
Table 76. MassBiologics Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 77. MassBiologics Recent Development
Table 78. Richter-Helm Company Details
Table 79. Richter-Helm Business Overview
Table 80. Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product
Table 81. Richter-Helm Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 82. Richter-Helm Recent Development
Table 83. FUJIFILM Diosynth Biotechnologies Company Details
Table 84. FUJIFILM Diosynth Biotechnologies Business Overview
Table 85. FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product
Table 86. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 87. FUJIFILM Diosynth Biotechnologies Recent Development
Table 88. Lonza Company Details
Table 89. Lonza Business Overview
Table 90. Lonza Viral Vectors and Plasmid DNA Manufacturing Product
Table 91. Lonza Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 92. Lonza Recent Development
Table 93. Aldevron Company Details
Table 94. Aldevron Business Overview
Table 95. Aldevron Viral Vectors and Plasmid DNA Manufacturing Product
Table 96. Aldevron Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 97. Aldevron Recent Development
Table 98. Eurogentec Company Details
Table 99. Eurogentec Business Overview
Table 100. Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product
Table 101. Eurogentec Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 102. Eurogentec Recent Development
Table 103. Cell and Gene Therapy Catapult Company Details
Table 104. Cell and Gene Therapy Catapult Business Overview
Table 105. Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product
Table 106. Cell and Gene Therapy Catapult Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 107. Cell and Gene Therapy Catapult Recent Development
Table 108. Biovian Company Details
Table 109. Biovian Business Overview
Table 110. Biovian Viral Vectors and Plasmid DNA Manufacturing Product
Table 111. Biovian Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 112. Biovian Recent Development
Table 113. Thermo Fisher Scientific (Brammer Bio) Company Details
Table 114. Thermo Fisher Scientific (Brammer Bio) Business Overview
Table 115. Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product
Table 116. Thermo Fisher Scientific (Brammer Bio) Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 117. Thermo Fisher Scientific (Brammer Bio) Recent Development
Table 118. VGXI Company Details
Table 119. VGXI Business Overview
Table 120. VGXI Viral Vectors and Plasmid DNA Manufacturing Product
Table 121. VGXI Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 122. VGXI Recent Development
Table 123. PlasmidFactory Company Details
Table 124. PlasmidFactory Business Overview
Table 125. PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product
Table 126. PlasmidFactory Revenue in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025) & (US$ Million)
Table 127. PlasmidFactory Recent Development
Table 128. Viral Vectors and Plasmid DNA Manufacturing Market Trends
Table 129. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
Table 130. Viral Vectors and Plasmid DNA Manufacturing Market Challenges
Table 131. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Viral Vectors and Plasmid DNA Manufacturing Product Picture
Figure 2. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Type: 2024 VS 2031
Figure 3. Plasmid DNA Features
Figure 4. Viral Vectors Features
Figure 5. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Application: 2024 VS 2031
Figure 6. Cancers
Figure 7. Inherited Disorders
Figure 8. Viral Infections
Figure 9. Others
Figure 10. Viral Vectors and Plasmid DNA Manufacturing Report Years Considered
Figure 11. Global Viral Vectors and Plasmid DNA Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Viral Vectors and Plasmid DNA Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Viral Vectors and Plasmid DNA Manufacturing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Viral Vectors and Plasmid DNA Manufacturing Market Share by Players in 2024
Figure 19. Global Top Viral Vectors and Plasmid DNA Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vectors and Plasmid DNA Manufacturing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Viral Vectors and Plasmid DNA Manufacturing Revenue in 2024
Figure 21. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
Figure 22. North America Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
Figure 23. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
Figure 24. Europe Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
Figure 25. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
Figure 26. China Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
Figure 27. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Type (2020-2025)
Figure 28. Japan Viral Vectors and Plasmid DNA Manufacturing Market Share by Application (2020-2025)
Figure 29. BioReliance Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 30. Cobra Biologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 31. Oxford BioMedica Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 32. UniQure Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 33. FinVector Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 34. MolMed Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 35. MassBiologics Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 36. Richter-Helm Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 37. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 38. Lonza Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 39. Aldevron Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 40. Eurogentec Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 41. Cell and Gene Therapy Catapult Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 42. Biovian Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 43. Thermo Fisher Scientific (Brammer Bio) Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 44. VGXI Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 45. PlasmidFactory Revenue Growth Rate in Viral Vectors and Plasmid DNA Manufacturing Business (2020-2025)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
